JAK1 and juvenile myelomonocytic leukemia: Among other intracellular signaling molecules, mitogen-activated protein kinase kinase (MEK) and janus protein tyrosine kinase 1/2 (JAK1/2) are hyperactive in JMML [8,10,11].